Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating inflammatory bowel disease by administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody

Methods of treating inflammatory bowel disease by administering tumor necrosis factor-like ligand 1A or an agonistic death-domain receptor 3 antibody

US Patent 10160805 · Granted Dec 25, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Steroid compounds as Treg modulators and uses thereof2024
Vasointestinal peptide receptor inhibitors for enhancement of gastrointestinal h2024
Amido compounds as RORγt modulators and uses thereof2020
Methods for treating psoriatic arthritis2019
Maternal TH17 cells and psychiatric disorders2018
Causative agents and diagnostic methods relating to rheumatoid arthritis2018
Causative agents and diagnostic methods relating to rheumatoid arthritis2018
Amido compounds as RORγt modulators and uses thereof2017
Steroid compounds as RORyt modulators and uses thereof2016
Methods for in vitro differentiation of TH-17+ cells2016
Amido compounds as RORγt modulators and uses thereof2016
GPR15-mediated homing and uses thereof2016